AU2002367426A1 - Neurotrophic factor production/secretion accelerator - Google Patents

Neurotrophic factor production/secretion accelerator

Info

Publication number
AU2002367426A1
AU2002367426A1 AU2002367426A AU2002367426A AU2002367426A1 AU 2002367426 A1 AU2002367426 A1 AU 2002367426A1 AU 2002367426 A AU2002367426 A AU 2002367426A AU 2002367426 A AU2002367426 A AU 2002367426A AU 2002367426 A1 AU2002367426 A1 AU 2002367426A1
Authority
AU
Australia
Prior art keywords
neurotrophic factor
factor production
secretion accelerator
secretion
accelerator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002367426A
Inventor
Masatoshi Hazama
Norihisa Iwakami
Toru Kawamura
Tsuyoshi Maekawa
Takeshi Miyazaki
Yu Momose
Nozomu Sakai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU2002367426A1 publication Critical patent/AU2002367426A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002367426A 2001-12-28 2002-12-26 Neurotrophic factor production/secretion accelerator Abandoned AU2002367426A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001-401380 2001-12-28
JP2001401380 2001-12-28
PCT/JP2002/013654 WO2003057215A1 (en) 2001-12-28 2002-12-26 Neurotrophic factor production/secretion accelerator

Publications (1)

Publication Number Publication Date
AU2002367426A1 true AU2002367426A1 (en) 2003-07-24

Family

ID=19189767

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002367426A Abandoned AU2002367426A1 (en) 2001-12-28 2002-12-26 Neurotrophic factor production/secretion accelerator

Country Status (2)

Country Link
AU (1) AU2002367426A1 (en)
WO (1) WO2003057215A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2278346T3 (en) 2003-08-20 2007-08-01 Eli Lilly And Company COMPOUNDS, PROCEDURES AND FORMULATIONS FOR ORAL SUPPLY OF A PEPTIDE COMPOUND (LPG) -1 OF THE TYPE OF GLUCAGON OR AN AGONISTIC PEPTIDE (LPG) -4 OF THE RECEIVER 4 OF MELACORTINE (MC4).
EP1658285B1 (en) * 2003-08-20 2007-05-02 Eli Lilly And Company Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
NL2000351C2 (en) 2005-12-22 2007-09-11 Pfizer Prod Inc Estrogen modulators.
EP1939180A1 (en) 2006-12-20 2008-07-02 sanofi-aventis Heteroarylacrylamides and their use as pharmaceuticals for the stimulation of the expression of endothelial NO synthase
AR086156A1 (en) 2011-04-28 2013-11-20 Japan Tobacco Inc AMIDA COMPOUND AND ITS MEDICINAL USE
CN113480489A (en) * 2021-08-19 2021-10-08 贵州大学 Isoxazole biphenyl compound and preparation method and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0517354A (en) * 1991-07-03 1993-01-26 Nichiban Co Ltd Percutaneous absorption preparation containing isoxazole derivative
JPH08175992A (en) * 1994-12-21 1996-07-09 Sagami Chem Res Center Agent for promoting production of nerve growth factor and condensed ring type oxazole compound
AR035016A1 (en) * 1999-08-25 2004-04-14 Takeda Chemical Industries Ltd COMPOSITION OF AZOL PROMOTER OF PRODUCTION / SECRETION OF NEUROTROFINE, COMPOSITE PRODROGA OF THE SAME, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND USE OF THE SAME TO PREPARE THIS LAST.
CA2429426A1 (en) * 2000-11-17 2002-05-23 Takeda Chemical Industries, Ltd. Isoxazole derivatives
JP4422949B2 (en) * 2001-06-26 2010-03-03 武田薬品工業株式会社 TGF-β superfamily production / secretion promoter

Also Published As

Publication number Publication date
WO2003057215A1 (en) 2003-07-17

Similar Documents

Publication Publication Date Title
AU2002328724A1 (en) Methanol production process
AU2003227473A1 (en) Neurotrophic factor production accelerator
AU2002362195A1 (en) Dimmer element and production method therefor
AU2002367426A1 (en) Neurotrophic factor production/secretion accelerator
AU2002361369A1 (en) Glass composite
AUPR349501A0 (en) Cellular production control
AU2002302604A1 (en) Process connection
AU2002318513A1 (en) Novel neurotrophic factors
AUPR898601A0 (en) Improved pressplate for laminate production
AU2002312846A1 (en) Exopolysaccharide production
AU2002303418A1 (en) Methods for producing recombinant coronavirus
AU2002301101A1 (en) Elevating Bed
AU2002331948A1 (en) Protein production
AU2002310865A1 (en) Glass holloware production
AU2002241337A1 (en) Production system
AUPR518501A0 (en) Yin yang-1
AU2002257482A1 (en) Capacitance controlling process
AU2002338971A1 (en) Method for the production of biperiden ii
AU2002340724A1 (en) Hf-reducing green roofing
AU2002247674A1 (en) Method for producing recombinant trypsin
AU2002315886A1 (en) Tgf-ss superfamily production/secretion promoter
AU2002348129A1 (en) Decorative structure
AU2002244929A1 (en) Controller
AUPR513501A0 (en) Controller
AU2002364778A1 (en) Laminate production utilising improved pressplate

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase